DHSC announces launch of £10 million Respiratory Transformation Partnership
The Department of Health and Social Care (DHSC) has announced the launch of the Respiratory Transformation Partnership (RTP), a £10 million co-funded programme involving NHS England, the Office for Life Sciences, 15 health innovation networks and four pharmaceutical companies: AstraZeneca, Chiesi, GSK and Sanofi. The RTP aims to improve care for asthma and chronic obstructive pulmonary disease patients by shifting treatment from hospitals into community-based care. It will use data and digital tools to identify patients who would benefit from targeted treatments, expand access to biologic medicines and enable community and primary care teams to deliver care within community settings. It is also intended to reduce emergency admissions and alleviate pressure on hospitals, particularly during winter. The RTP is chaired by the National Clinical Director for Respiratory Disease, Jonathan Fuld, and co-ordinated by Health Innovation Oxford and Thames Valley.